301156 美农生物
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)1.8207.4316.4237.9779.494
总资产报酬率 ROA (%)1.5906.7706.0877.3077.412
投入资产回报率 ROIC (%)1.8077.4256.4137.8988.416

边际利润分析
销售毛利率 (%)31.47930.64328.81629.93129.035
营业利润率 (%)9.03410.79411.12813.22412.110
息税前利润/营业总收入 (%)10.05810.79110.35812.97010.807
净利润/营业总收入 (%)8.4599.76610.12012.49910.861

收益指标分析
经营活动净收益/利润总额(%)141.26994.11594.34882.535104.279
价值变动净收益/利润总额(%)4.4003.8233.0515.839-1.230
营业外收支净额/利润总额(%)-0.0240.3082.2945.004-0.419

偿债能力分析
流动比率 (X)3.9974.27911.38414.7845.959
速动比率 (X)2.9803.5109.80212.7345.343
资产负债率 (%)13.37711.9175.7484.73511.855
带息债务/全部投入资本 (%)0.976-0.238-0.3020.0041.517
股东权益/带息债务 (%)10,111.435-41,997.674-33,123.0412,243,683.7556,478.289
股东权益/负债合计 (%)647.561739.1071,639.8752,011.918743.514
利息保障倍数 (X)9.797-301.723-10.049-13.639-8.630

营运能力分析
应收账款周转天数 (天)68.23571.30666.97168.22573.182
存货周转天数 (天)78.04265.45174.93872.04970.156